ACHV · Achieve Life Sciences, Inc.
Market Cap
$873.64M
Shares
102.90M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
FY2019
Net Income
-$54.65M
-37.2%
FY2025
Diluted EPS
-$1.25
-0.8%
FY2025
Operating Cash Flow
-$49.47M
-66.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| $26.42M | — | $22.82M | $15.81M | $30.08M | $23.97M | $6.88M | $9.67M | $5.87M | $3.1M | $286K | $25.11M | $46.22M | $55.32M | $39.95M | $21.55M | $18.48M | $20.21M | |
| $25.92M | — | $16.25M | $11.44M | $10.72M | $9.13M | $7.87M | $6.85M | $6.95M | $3.53M | $1.43M | $11.81M | $10.63M | $9.89M | $7.79M | $6.23M | $5.84M | $3.96M | |
| $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | — | — | — | — | — | — | — | |
| $226K | $228K | $229K | $228K | $236K | $250K | $255K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | -$1.66M | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $36.91M | $56.58M | $65.21M | — | — | — | — | |
| $58.28M | $54.88M | $39.07M | $27.25M | $40.8M | $33.09M | $14.75M | $16.53M | $12.81M | $6.63M | $1.71M | $36.91M | $56.58M | $65.21M | $46.08M | $27.78M | $28.36M | $28.12M | |
| $994K | $819K | $2.18M | $2.85M | $1.79M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $2.75M | $1.5M | $2.36M | $825K | $199K | $17K | $69K | $170K | $171K | $21K | $203K | $119K | $35K | $150K | $292K | $220K | $86K | $47K | |
| -$55.76M | $232K | -$758K | -$2.57M | -$1.55M | -$58K | $20K | $133K | $126K | -$7M | -$24K | $1.95M | $3.23M | $3.48M | $4.89M | $7.61M | -$839K | $117K | |
| — | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M | -$14.73M | -$16.4M | -$12.69M | -$13.63M | -$1.74M | — | — | — | -$21.1M | -$14.67M | -$15.58M | -$2.47M | |
| — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | — | -$3M | $3.01M | |
| -$114.04M | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M | -$14.73M | -$16.4M | -$12.69M | -$10.58M | -$1.23M | -$828K | -$26.24M | -$31.85M | -$21.1M | -$14.67M | -$12.58M | -$5.48M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -$14.67M | -$12.58M | -$5.48M | |
| -$114.13M | -$54.67M | -$39.8M | -$29.82M | -$42.35M | — | — | -$16.4M | -$12.69M | -$10.58M | -$1.23M | -$16.79M | -$26.26M | -$31.84M | -$21.1M | -$14.64M | -$12.62M | — | |
| USD/shares | -$1.50 | -$1.25 | -$1.24 | -$1.50 | -$4.00 | -$4.08 | -$5.42 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$1.50 | -$1.25 | -$1.24 | -$1.50 | -$4.00 | -$4.08 | -$5.42 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 23.97K | 106.15 | 1061.5 | 904.94K | 734.17K | 676.14K | 486.47K | 351.55K | — |
| shares | — | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 23.97K | 106.15 | 1061.5 | 904.94K | 734.17K | 676.14K | 486.47K | 351.55K | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
949858
CUSIP
004468500
13F (30d)
90 filings
90 filers
Visit website
Investor relations